Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06948955 |
| Title | Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors |
| Recruitment | Available |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | No |
| Sponsors | Cogent Biosciences, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCLA Department of Medicine- Hematology/Oncology | AVAILABLE | Los Angeles | California | 90095 | United States | Details |
| Orlando Health | AVAILABLE | Orlando | Florida | 32806 | United States | Details |
| Dana Farber Cancer Institute (DFCI) | AVAILABLE | Boston | Massachusetts | 02215 | United States | Details |
| MD Anderson Cancer Center | AVAILABLE | Houston | Texas | 77030 | United States | Details |